Recombinant Human BMP2

Cat. No.
Cat. No. Z100085
Name Recombinant Human BMP2
Description BMPs are proteins that act to induce the differentiation of mesenchymal-type cells into chondrocytes and osteoblasts before initiating bone formation. They promote the differentiation of cartilage-forming cells and bone-forming cells near sites of fractures but also at ectopic locations. Some of the proteins induce the synthesis of alkaline phosphatase and collagen in osteoblasts. Some BMPs act directly on osteoblasts and promote their maturation while at the same time suppressing myogenous differentiation. Other BMPs promote the conversion of typical fibroblasts into chondrocytes and are capable also of inducing the expression of an osteoblast phenotype in non-osteogenic cell types. Intracellular signaling following engagement of receptors for some BMP proteins has been shown to involve the action of SMAD proteins. BMP-2 wild type binds to its cellular receptors via two distinct binding epitopes. The large epitope 1 is responsible for the high-affinity binding to the BMPR-IA receptor, the smaller epitope 2 provides the low-affinity binding to the receptor BMPR-II. Recombinant Human Bone Morphogenetic Protein-2 is a homodimeric, non-glycosylated polypeptide chain containing two 115 amino acid subunits with a total molecular mass of 26kDa.
Organism Human (H. sapiens)
Unit quantity 10 µg
Family TGF-beta Super-family
Aliases BMP-2, BMP-2A
Recombinant Human Bone Morphogenetic Protein 2 (BMP2)
Gene Symbol BMP2
Gene ID 650
Accession Number P12643
Source E. coli
Species Human (H. sapiens)
Appearance Lyophilized Powder
Molecular Weight 26 kDa
Endotoxin Level <1.0 EU/µg of recombinant protein as determined by the LAL method
Purity >95% as determined by SDS-PAGE
Formulation Lyophilized from a 0.2µm filtered solution containing 10mM sodium citrate, pH 3.5
Function The ED50 as determined by its ability to induce alkaline phosphatase production by C2C12 myogenic cells was found to be less than 50 ng/mL
Reconstitution A quick spin of the vial followed by reconstitution in 20mM AcOH (acetic Acid) to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.
Storage The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.
Usage For research use only. Not for diagnostic or therapeutic use.
Material Citation If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. Z100085
Print & Download Datasheet
There are no FAQs for this product yet!
There are no references for this product yet!
This product has no review yet.
Controls and Related Product:

1.0 mg

50 µg

50 µg

10 µg